To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

V 116TH CONGRESS 1ST SESSION H. R. 2855 To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved. IN THE HOUSE OF REPRESENTATIVES MAY 20, 2019 Mr. KING of Iowa introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. DEEMED APPROVAL OF APPLICATION FOR 3 COMPASSIONATE USE OF THE GENE THER- 4 APY ANTISENSE OLIGONUCLEOTIDES. 5 Notwithstanding the Federal Food, Drug, and Cos- 6 metic Act (21 U.S.C. 301 et seq.) or any other provision 7 of law, the application submitted by Jaci Hermstad to the 8 VerDate Sep 11 2014 02:38 May 21, 2019 Jkt 089200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2855.IH H2855 pbinns on DSK79D2C42PROD with BILLS 2 •HR 2855 IH Food and Drug Administration for compassionate use of 1 the gene therapy antisense oligonucleotides is deemed to 2 be approved. 3 Æ VerDate Sep 11 2014 02:38 May 21, 2019 Jkt 089200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\H2855.IH H2855 pbinns on DSK79D2C42PROD with BILLS